Search

Home > The Elective Rotation: A Critical Care Hospital Pharmacy Podcast > 913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
Podcast: The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
Episode:

913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
Category: Science & Medicine
Duration: 00:03:10
Publish Date: 2024-04-15 07:00:20
Description:

Show notes at pharmacyjoe.com/episode913.

In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.

The post 913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease? appeared first on Pharmacy Joe.
Total Play: 0